Duchenne Muscular Dystrophy Clinical Trial
— PUL in DMDOfficial title:
Performance of Upper Limb (PUL) in Duchenne Muscular Dystrophy
Verified date | May 2015 |
Source | Catholic University of the Sacred Heart |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics Committee |
Study type | Observational |
The literature on outcome measures assessing upper limbs in Duchenne muscular dystrophy
(DMD) is quite scanty. While there have been considerable advances for ambulant DMD boys, no
prospective study has so far been devoted to outcome measures in non ambulant patients, with
increasing complaints from families and patients. This information appears to be highly
important not only for a better understanding of the progression of the disease but also for
possible enrollment of patients in future trials.
The aim of this project is to identify outcome measures for non ambulant patients in an
Italian population of DMD patients. At least 200 non ambulant DMD boys and adults will be
included in the study. All patients will be assessed using the newly developed Performance
of Upper limb (PUL) test. This measure will be used at baseline and 6 and 12 months after
baseline. This will allow to monitor possible changes over time and the rate of changes in
patients with different level of ability and age. As part of this study the investigators
will also correlate possible changes in upper limb function with other measures of care and
function such as the EK scale.
The investigators aim to assess the suitability of the individual measures in a large number
of patients, trying to establish whether whole scales or individual items appear to be
relevant across ages and level of abilities. The investigators also aim to assess the
suitability of the selected measures in a multicentric setting and the quantity of training
required The data collected will also be analysed using Rasch analysis in order to improve
the statistical properties of the measures used.
Status | Active, not recruiting |
Enrollment | 300 |
Est. completion date | May 2015 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 4 Years to 35 Years |
Eligibility |
Inclusion Criteria: - proven DMD Exclusion Criteria: - severe mental retardation |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Italy | Catholic University | Rome |
Lead Sponsor | Collaborator |
---|---|
Catholic University of the Sacred Heart | Azienda Ospedaliera San Giovanni Battista, Bambino Gesù Hospital, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, IRCCS Eugenio Medea, IRCCS Fondazione Stella Maris, IRCCS National Neurological Institute "C. Mondino" Foundation, Istituto Giannina Gaslini, Maggiore Bellaria Hospital, Bologna, Nemo Clinical Center Milan, University of Messina, University of Naples, University of Padua |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | assessment of upper limb (PUL) | the test evaluates performance of upper limbs by providing a score for shoulder, elbow and distal domain and total score | 2 years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05575648 -
Dual Task in Duchenne Muscular Dystrophy
|
N/A | |
Terminated |
NCT03907072 -
Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06450639 -
An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT04335942 -
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
|
N/A | |
Active, not recruiting |
NCT04906460 -
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02500381 -
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
|
Phase 3 | |
Enrolling by invitation |
NCT05967351 -
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
|
Phase 3 | |
Recruiting |
NCT03067831 -
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Recruiting |
NCT01834040 -
Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy
|
Phase 1/Phase 2 | |
Completed |
NCT02246478 -
A Study of TAS-205 for Duchenne Muscular Dystrophy
|
Phase 1 | |
Active, not recruiting |
NCT01772043 -
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
|
N/A | |
Terminated |
NCT01168908 -
Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
|
Phase 2 | |
Completed |
NCT00758225 -
Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
|
Phase 2 | |
Completed |
NCT03680365 -
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
|
||
Recruiting |
NCT03513367 -
The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM.
|
||
Recruiting |
NCT05712447 -
Duchenne Muscular Dystrophy Video Assessment Registry
|
||
Recruiting |
NCT01484678 -
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
|
||
Completed |
NCT03319030 -
Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)
|
||
Terminated |
NCT01753804 -
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.
|
N/A | |
Completed |
NCT02530905 -
Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
|
Phase 1 |